Tickers: XCNQ:DOSE
Tags: Cannabis
January 17 2019 / TheNewswire / On this edition of NewlyTrading, Rapid Dose Therapeutics Corp. is a Canadian bio-technology company which povides proprietary drug delivery technologies to the pharmaceutical and healthcare manufacturing industries. Introducing QuickStrip(TM) Rapid Dose management believes it will take oral cannabis delivery to the next level and is now lining up partners. CEO Mark Upsdell joins host Jim Ripley.
-
-
For further information, please contact Mr. Mark Upsdell at 416-477-1052 or via email info@rapid-dose.com
Advisory Regarding Forward Looking Statements
This Podcast contains forward-looking statements. Users of forward-looking statements are cautioned that actual results may vary from forward-looking statements contained herein. Forward-looking statements include, but are not limited to: expectations, opinions, forecasts, projections and other similar statements concerning anticipated future events, conditions or results that are not historical facts. In certain cases, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". While the Company has based these forward-looking statements on its expectations about future events as at the date those statements were prepared, the statements are not a guarantee of the Company's future performance. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot give any assurance that such expectations will prove to be correct.
Copyright (c) 2019 TheNewswire - All rights reserved.
